Guest Kevin 4

What Happened

• Kevin Guest, CEO and Executive Chairman of USANA Health Sciences (USNA), was granted 82,726 restricted stock units (RSUs) on February 19, 2026. The award is reported as a derivative grant at $0.00 (no cash purchase); each RSU represents the contingent right to receive one share upon vesting.

Key Details

• Transaction date: 2026-02-19; Form 4 filed: 2026-02-23 (filed within the typical two-business-day window).
• Transaction type/code: Award/Grant (A) — derivative (restricted stock units).
• Shares/units granted: 82,726 RSUs; reported acquisition price: $0.00.
• Vesting: 25% vests on each February 19 thereafter (per footnote).
• Footnotes: F1 — each RSU converts to one share of USNA common stock; F2 — vesting schedule is 25% per year beginning Feb 19, 2027.
• Shares owned after transaction: not specified in the supplied filing data.

Context

• RSU grants are a form of compensation, not an open-market purchase or sale. They become actual shares only as they vest, so this grant does not reflect an immediate cash investment by the insider. Such awards are common for executive compensation and should be viewed as part of pay rather than a direct bullish market signal.